Back to Trades
Daly James M
DirectorCIK 0001560782
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 9
- Buy transactions
- 0
- Sell transactions
- 1
- Companies
- 3
- Active
- 2025–2026
Daly James M, Director, has filed 9 SEC reports (2025–2026), spread across 3 companies, totaling $2.8M in disclosed volume. Weighing $0 bought versus $671.0K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
9 loaded
| Jul 16 | CYTK CYTOKINETICS INC | Daly James M | Director | Grant | $12.5K |
| Jun 18 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Daly James M | Director | Grant | $382.9K |
| Jun 1 | ACAD ACADIA PHARMACEUTICALS INC | Daly James M | Insider | Exercise | $346.6K |
| May 27 | CYTK CYTOKINETICS INC | Daly James M | Director | Grant | $331.8K |
| Apr 15 | CYTK CYTOKINETICS INC | Daly James M | Director | Grant | $12.5K |
| Jan 20 | CYTK CYTOKINETICS INC | Daly James M | Director | Grant | $12.5K |
| Nov 12 | ACAD ACADIA PHARMACEUTICALS INC | Daly James M | Insider | Sell | $671.0K |
| Aug 20 | CYTK CYTOKINETICS INC | Daly James M | Director | Award | $1.0M |
| Aug 20 | CYTK CYTOKINETICS INC | Daly James M | Director | Other | $0 |
9 filings